These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 35411336)

  • 41. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
    Hu Y; Liu L; Lu X
    Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence for an ACE2-Independent Entry Pathway That Can Protect from Neutralization by an Antibody Used for COVID-19 Therapy.
    Hoffmann M; Sidarovich A; Arora P; Krüger N; Nehlmeier I; Kempf A; Graichen L; Winkler MS; Niemeyer D; Goffinet C; Drosten C; Schulz S; Jäck HM; Pöhlmann S
    mBio; 2022 Jun; 13(3):e0036422. PubMed ID: 35467423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Shedding Light on the Inhibitory Mechanisms of SARS-CoV-1/CoV-2 Spike Proteins by ACE2-Designed Peptides.
    Freitas FC; Ferreira PHB; Favaro DC; Oliveira RJ
    J Chem Inf Model; 2021 Mar; 61(3):1226-1243. PubMed ID: 33619962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach.
    Di Paola L; Hadi-Alijanvand H; Song X; Hu G; Giuliani A
    J Proteome Res; 2020 Nov; 19(11):4576-4586. PubMed ID: 32551648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Computational Alanine Scanning and Structural Analysis of the SARS-CoV-2 Spike Protein/Angiotensin-Converting Enzyme 2 Complex.
    Laurini E; Marson D; Aulic S; Fermeglia M; Pricl S
    ACS Nano; 2020 Sep; 14(9):11821-11830. PubMed ID: 32833435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. SARS-CoV-2 Spike Glycoprotein and ACE2 Interaction Reveals Modulation of Viral Entry in Wild and Domestic Animals.
    Praharaj MR; Garg P; Kesarwani V; Topno NA; Khan RIN; Sharma S; Panigrahi M; Mishra BP; Mishra B; Kumar GS; Gandham RK; Singh RK; Majumdar S; Mohapatra T
    Front Med (Lausanne); 2021; 8():775572. PubMed ID: 35360445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenothiazines inhibit SARS-CoV-2 cell entry via a blockade of spike protein binding to neuropilin-1.
    Hashizume M; Takashima A; Ono C; Okamoto T; Iwasaki M
    Antiviral Res; 2023 Jan; 209():105481. PubMed ID: 36481388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.
    Liu Y; Hu G; Wang Y; Ren W; Zhao X; Ji F; Zhu Y; Feng F; Gong M; Ju X; Zhu Y; Cai X; Lan J; Guo J; Xie M; Dong L; Zhu Z; Na J; Wu J; Lan X; Xie Y; Wang X; Yuan Z; Zhang R; Ding Q
    Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33658332
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19.
    Ma LL; Liu HM; Liu XM; Yuan XY; Xu C; Wang F; Lin JZ; Xu RC; Zhang DK
    Eur J Med Chem; 2021 Dec; 226():113857. PubMed ID: 34628234
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19.
    Esparza TJ; Chen Y; Martin NP; Bielefeldt-Ohmann H; Bowen RA; Tolbert WD; Pazgier M; Brody DL
    MAbs; 2022; 14(1):2047144. PubMed ID: 35289719
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of Binding Sites on SARS-CoV-2 Spike Protein Receptor-Binding Domain by Molecular Dynamics Simulations in Mixed Solvents.
    Jokinen EM; Gopinath K; Kurkinen ST; Pentikainen OT
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(4):1281-1289. PubMed ID: 33914685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2).
    Zeng MS; Yu WD; Wang HX; Liu JY; Xu PP
    Int J Biol Macromol; 2021 Jul; 183():2248-2261. PubMed ID: 34111482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness.
    Faisal HMN; Katti KS; Katti DR
    Chem Phys; 2021 Nov; 551():111353. PubMed ID: 34511698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients.
    Zhang H; Shao L; Lin Z; Long QX; Yuan H; Cai L; Jiang G; Guo X; Yang R; Zhang Z; Zhang B; Liu F; Li Z; Ma Q; Zhang YW; Huang AL; Wang Z; Zhao Y; Xu H
    Signal Transduct Target Ther; 2022 Aug; 7(1):261. PubMed ID: 35915083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity.
    Adhikary P; Kandel S; Mamani UF; Mustafa B; Hao S; Qiu J; Fetse J; Liu Y; Ibrahim NM; Li Y; Lin CY; Omoscharka E; Cheng K
    Adv Ther (Weinh); 2021 Jul; 4(7):2100087. PubMed ID: 34179347
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
    Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
    J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Erratum to "Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production".
    FASEB J; 2023 Apr; 37(4):e22850. PubMed ID: 36884387
    [No Abstract]   [Full Text] [Related]  

  • 58. A two-step infection model: From SARS-CoV-2 entry and trafficking to egress and spread.
    You L; Ying B
    MedComm (2020); 2023 Jun; 4(3):e295. PubMed ID: 37274936
    [No Abstract]   [Full Text] [Related]  

  • 59. Targeted protein S-nitrosylation of ACE2 as potential treatment to prevent spread of SARS-CoV-2 infection.
    Oh CK; Nakamura T; Beutler N; Zhang X; Piña-Crespo J; Talantova M; Ghatak S; Trudler D; Carnevale LN; McKercher SR; Bakowski MA; Diedrich JK; Roberts AJ; Woods AK; Chi V; Gupta AK; Rosenfeld MA; Kearns FL; Casalino L; Shaabani N; Liu H; Wilson IA; Amaro RE; Burton DR; Yates JR; Becker C; Rogers TF; Chatterjee AK; Lipton SA
    bioRxiv; 2022 Apr; ():. PubMed ID: 35411336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeted protein S-nitrosylation of ACE2 inhibits SARS-CoV-2 infection.
    Oh CK; Nakamura T; Beutler N; Zhang X; Piña-Crespo J; Talantova M; Ghatak S; Trudler D; Carnevale LN; McKercher SR; Bakowski MA; Diedrich JK; Roberts AJ; Woods AK; Chi V; Gupta AK; Rosenfeld MA; Kearns FL; Casalino L; Shaabani N; Liu H; Wilson IA; Amaro RE; Burton DR; Yates JR; Becker C; Rogers TF; Chatterjee AK; Lipton SA
    Nat Chem Biol; 2023 Mar; 19(3):275-283. PubMed ID: 36175661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.